Stage D2 Prostatic carcinoma
Also known as: Stage D Prostate Cancer / Stage D2 Prostate cancer / Prostate cancer stage D / D Prostate cancer / Carcinoma of the prostate stage IV / Prostate cancer stage IV / Prostatic cancer stage IV
Drug | Drug Name | Drug Description |
---|---|---|
DB06719 | Buserelin | A LHRH agonist used for the palliative treatment of hormone-dependent advanced carcinoma of the prostate gland in males and treatment of endometriosis in females. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB06719 | Buserelin | Lutropin-choriogonadotropic hormone receptor | target |
DB06719 | Buserelin | Gonadotropin-releasing hormone receptor | target |
DB06719 | Buserelin | Aromatase | enzyme |
Drug | Drug Name | Phase | Status | Count |
---|